Hasil Pencarian - Sumanta Kumar Pal

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?

    Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new? oleh Alexander Chehrazi-Raffle, Sumanta Kumar Pal

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors

    Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors oleh Sumanta Kumar Pal, Robert A. Figlin

    Diterbitkan 2010-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Critical appraisal of cabazitaxel in the management of advanced prostate cancer

    Critical appraisal of cabazitaxel in the management of advanced prostate cancer oleh Sumanta Kumar Pal, Przemyslaw Twardowski, Oliver Sartor

    Diterbitkan 2010-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Conditional Survival in de novo Metastatic Urothelial Carcinoma.

    Conditional Survival in de novo Metastatic Urothelial Carcinoma. oleh Sumanta Kumar Pal, Yulan Ingrid Lin, Bertram Yuh, Kara DeWalt, Austin Kazarian, Nicholas Vogelzang, Rebecca A Nelson

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy

    Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy oleh Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J. Philip, Jo Ann Hsu, Nazli Dizman, Ulka Vaishampayan, Tanya Dorff, Sumanta Kumar Pal

    Diterbitkan 2019-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation

    Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation oleh Jamie A. Kmak, Nikita Agarwal, Yuting He, Andreas M. Heilmann, Vincent A. Miller, Jeffrey S. Ross, Sumanta Kumar Pal, Siraj M. Ali, Deepak Kilari

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma

    Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma oleh Cristiane Decat Bergerot, Dena Battle, Paulo Gustavo Bergerot, Nazli Dizman, Eric Jonasch, Hans J. Hammers, Daniel J. George, Axel Bex, Borje Ljungberg, Sumanta Kumar Pal, Michael D. Staehler

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database

    Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database oleh Gabriella Del Bene, Fabio Calabrò, Diana Giannarelli, Elizabeth R. Plimack, Lauren C. Harshman, Evan Y. Yu, Simon J. Crabb, Sumanta Kumar Pal, Ajjai S. Alva, Thomas Powles, Ugo De Giorgi, Neeraj Agarwal, Aristotelis Bamias, Sylvain Ladoire, Andrea Necchi, Ulka N. Vaishampayan, Günter Niegisch, Joaquim Bellmunt, Jack Baniel, Matthew D. Galsky, Cora N. Sternberg

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: